drugset / Trial / NCT00461097

Oral Immunotherapy for Childhood Egg Allergy

NCT00461097 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if oral immunotherapy (OIT) will desensitize a child with an allergy to egg and eventually lead to the development of tolerance to egg.

Timeline

Start
2007-05
Primary completion
2010-12
Completion
2013-12

Outcome

Met primary endpoint

registry Egg Oral Immunotherapy (OIT) vs Placebo; p = 0.025; Risk Difference (RD) 27.5 (95% CI 4.3 to 43.9) NCT00461097 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Egg white solid powder Unknown 2 g Oral

Indications